Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NEUROTOXIC PYRIDINIUM METABOLITE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 40 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kalgutkar, AS; Dalvie, DK; Castagnoli, N; Taylor, TJ
      Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors

      CHEMICAL RESEARCH IN TOXICOLOGY
    2. Shin, JG; Kane, K; Flockhart, DA
      Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    3. Fang, J; Mckay, G; Song, JX; Remillrd, A; Li, XM; Midha, K
      In vitro characterization of the metabolism of haloperidol using recombinant cytochrome P450 enzymes and human liver microsomes

      DRUG METABOLISM AND DISPOSITION
    4. Igarashi, K; Sugiyama, Y; Kasuya, F; Inoue, H; Matoba, R; Castagnoli, N
      Analysis of citrulline in rat brain tissue after perfusion with haloperidol by liquid chromatography-mass spectrometry

      JOURNAL OF CHROMATOGRAPHY B
    5. Petzer, JP; Bergh, JJ; Mienie, LJ; Castagnoli, N; Van der Schyf, CJ
      Metabolic defects caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and by HPTP (the tetrahydropyridinyl analog of haloperidol), in rats

      LIFE SCIENCES
    6. Igarashi, K; Sugiyama, Y; Kasuya, F; Saiki, K; Yamakawa, T; Ohata, S
      Determination of 1-methyl-1,2,3,4-tetrahydroisoquinoline in mouse brain after treatment with haloperidol by gas chromatography-selected ion monitoring

      JOURNAL OF CHROMATOGRAPHY B
    7. Elkashef, AM; Wyatt, RJ
      Tardive dyskinesia: Possible involvement of free radicals and treatment with vitamin E

      SCHIZOPHRENIA BULLETIN
    8. Kudo, S; Ishizaki, T
      Pharmacokinetics of haloperidol - An update

      CLINICAL PHARMACOKINETICS
    9. Balijepalli, S; Boyd, MR; Ravindranath, V
      Inhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation

      NEUROPHARMACOLOGY
    10. Bryan-Lluka, LJ; Siebert, GA; Pond, SM
      Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    11. Mienie, LJ; Bergh, JJ; Bloomquist, JR; Castagnoli, N; Steyn, SJ; Van der Schyf, CJ
      p-Fluorophenylglycine in the urine of baboons treated with HPTP, the tetrahydropyridine analog of haloperidol

      LIFE SCIENCES
    12. Ng, HP; May, K; Bauman, JG; Ghannam, A; Islam, I; Liang, M; Horuk, R; Hesselgesser, J; Snider, RM; Perez, HD; Morrissey, MM
      Discovery of novel non-peptide CCR1 receptor antagonists

      JOURNAL OF MEDICINAL CHEMISTRY
    13. Halliday, GM; Pond, SM; Cartwright, H; McRitchie, DA; Castagnoli, N; Van der Schyf, CJ
      Clinical and neuropathological abnormalities in baboons treated with HPTP,the tetrahydropyridine analog of haloperidol

      EXPERIMENTAL NEUROLOGY
    14. Kornhuber, J; Schultz, A; Wiltfang, J; Meineke, I; Gleiter, CH; Zochling, R; Boissl, KW; Leblhuber, F; Riederer, P
      Persistence of haloperidol in human brain tissue

      AMERICAN JOURNAL OF PSYCHIATRY
    15. BOEHME CL; STROBEL HW
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHODS FOR THE ANALYSIS OF HALOPERIDOL AND CHLORPROMAZINE METABOLISM IN-VITRO BY PURIFIED CYTOCHROME-P450 ISOFORMS

      Journal of chromatography B. Biomedical sciences and applications
    16. IGARASHI K
      THE POSSIBLE ROLE OF AN ACTIVE METABOLITE DERIVED FROM THE NEUROLEPTIC AGENT HALOPERIDOL IN DRUG-INDUCED PARKINSONISM

      Journal of toxicology. Toxin reviews
    17. Usuki, E; Van der Schyf, CJ; Castagnoli, N
      Metabolism of haloperidol and its tetrahydropyridine dehydration product HPTP

      DRUG METABOLISM REVIEWS
    18. BENEDETTI MS; TIPTON KF
      MONOAMINE OXIDASES AND RELATED AMINE OXIDASES AS PHASE-I ENZYMES IN THE METABOLISM OF XENOBIOTICS

      Journal of neural transmission. Supplementum
    19. KUDO S; ODOMI M
      INVOLVEMENT OF HUMAN CYTOCHROME-P450 3A4 IN REDUCED HALOPERIDOL OXIDATION

      European Journal of Clinical Pharmacology
    20. CASTAGNOLI N; RIMOLDI JM; BLOOMQUIST J; CASTAGNOLI KP
      POTENTIAL METABOLIC BIOACTIVATION PATHWAYS INVOLVING CYCLIC TERTIARY-AMINES AND AZAARENES

      Chemical research in toxicology
    21. MIENIE LJ; BERGH JJ; VANSTADEN E; STEYN SJ; POND SM; CASTAGNOLI N; VANDERSCHYF CJ
      METABOLIC DEFECTS CAUSED BY TREATMENT WITH THE TETRAHYDROPYRIDINE ANALOG OF HALOPERIDOL (HPTP), IN BABOONS

      Life sciences
    22. PRINCE JA; YASSIN MS; ORELAND L
      NEUROLEPTIC-INDUCED MITOCHONDRIAL ENZYME ALTERATIONS IN THE RAT-BRAIN

      The Journal of pharmacology and experimental therapeutics
    23. FANG JA; BAKER GB; COUTTS RT
      DETERMINATION OF 4-(4-CHLOROPHENYL)-4-HYDROXYPIPERIDINE, A METABOLITEOF HALOPERIDOL, BY GAS-CHROMATOGRAPHY WITH ELECTRON-CAPTURE DETECTION

      Journal of chromatography B. Biomedical applications
    24. POND SM
      ILLUMINATION OF THERAPEUTICS BY TOXICOLOGY - A PERSONAL VIEW

      Clinical and experimental pharmacology and physiology
    25. VANDERSCHYF CJ; DORMEHL IC; OLIVER DW; HUGO N; KEEVE R; MULLERGARTNER HW; POND SM; CASTAGNOLI N
      LONG-TERM TREATMENT WITH THE TETRAHYDROPYRIDINE ANALOG (HPTP) OF HALOPERIDOL INFLUENCES DOPAMINE LIGAND-BINDING IN BABOON BRAIN - AN [I-123] IODOBENZAMIDE (IBZM) SPECT STUDY

      Molecular brain research
    26. BRAND L; OLIVER DW; VANDERSCHYF CJ; POND SM; CASTAGNOLI N
      DOPAMINE-RECEPTOR BINDING OF UOROPHENYL)-4-OXOBUTYL]-1,2,3,6-TETRAHYDROPYRIDINE (HPTP), AN INTERMEDIATE METABOLITE OF HALOPERIDOL

      Life sciences
    27. IGARASHI K; KASUYA F; FUKUI M; USUKI E; CASTAGNOLI N
      STUDIES ON THE METABOLISM OF HALOPERIDOL (HP) - THE ROLE OF CYP3A IN THE PRODUCTION OF THE NEUROTOXIC PYRIDINIUM METABOLITE HPP-BRAIN FOLLOWING IP ADMINISTRATION OF HP( FOUND IN RAT)

      Life sciences
    28. FANG J; YU PH
      EFFECT OF HALOPERIDOL AND ITS METABOLITES ON DOPAMINE AND NORADRENALINE UPTAKE IN RAT BRAIN-SLICES

      Psychopharmacology
    29. FANG J; YU PH; GORROD JW; BOULTON AA
      INHIBITION OF MONOAMINE OXIDASES BY HALOPERIDOL AND ITS METABOLITES -PHARMACOLOGICAL IMPLICATIONS FOR THE CHEMOTHERAPY OF SCHIZOPHRENIA

      Psychopharmacology
    30. VANDERSCHYF CJ; CASTAGNOLI K; USUKI E; FOUDA HG; RIMOLDI JM; CASTAGNOLI N
      METABOLIC STUDIES ON HALOPERIDOL AND ITS TETRAHYDROPYRIDINE ANALOG INC57BL 6 MICE/

      Chemical research in toxicology
    31. SEE RE; CHAPMAN MA
      THE CONSEQUENCES OF LONG-TERM ANTIPSYCHOTIC DRUG ADMINISTRATION ON BASAL GANGLIA NEURONAL FUNCTION IN LABORATORY-ANIMALS

      Critical reviews in neurobiology
    32. BENEDETTI MS; DOSTERT P
      CONTRIBUTION OF AMINE OXIDASES TO THE METABOLISM OF XENOBIOTICS

      Drug metabolism reviews
    33. GARATTINI S
      PERSPECTIVES IN THE FIELD OF DRUG-METABOLISM

      Drug metabolism reviews
    34. TSANG MW; SHADER RI; GREENBLATT DJ
      METABOLISM OF HALOPERIDOL - CLINICAL IMPLICATIONS AND UNANSWERED QUESTIONS

      Journal of clinical psychopharmacology
    35. NAYLOR S; KAJBAF M; LAMB JH; JAHANSHAHI M; GORROD JW
      AN EVALUATION OF TANDEM MASS-SPECTROMETRY IN DRUG-METABOLISM STUDIES

      Biological mass spectrometry
    36. SEE RE
      ASSESSMENT OF STRIATAL EXTRACELLULAR DOPAMINE AND DOPAMINE METABOLITES BY MICRODIALYSIS IN HALOPERIDOL-TREATED RATS EXHIBITING ORAL DYSKINESIA

      Neuropsychopharmacology
    37. TOMLINSON AJ; BENSON LM; JOHNSON KL; NAYLOR S
      INVESTIGATION OF THE METABOLIC-FATE OF THE NEUROLEPTIC DRUG HALOPERIDOL BY CAPILLARY ELECTROPHORESIS ELECTROSPRAY-IONIZATION MASS-SPECTROMETRY

      Journal of chromatography. Biomedical applications
    38. FANG J; GORROD JW
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETECTION AND QUANTITATION OF HALOPERIDOL AND 7 OF ITS METABOLITES IN MICROSOMAL PREPARATIONS

      Journal of chromatography. Biomedical applications
    39. BURKHARDT C; KELLY JP; LIM YH; FILLEY CM; PARKER WD
      NEUROLEPTIC MEDICATIONS INHIBIT COMPLEX-I OF THE ELECTRON-TRANSPORT CHAIN

      Annals of neurology
    40. TOMLINSON AJ; BENSON LM; LANDERS JP; SCANLAN GF; FANG J; GORROD JW; NAYLOR S
      INVESTIGATION OF THE METABOLISM OF THE NEUROLEPTIC DRUG HALOPERIDOL BY CAPILLARY ELECTROPHORESIS

      Journal of chromatography


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 11:47:21